Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. reports the results of an Extraordinary General Meeting of Shareholders held on August 25, 2021. The filing date is August 26, 2021.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions regarding share capital.
Material Changes
Shareholders approved an amendment to the articles of association to increase the authorized share capital to EUR 26,400,000. The new capital structure is divided into:
- 110,000,000 ordinary shares
- 110,000,000 preferred shares
- Nominal value of EUR 0.12 per share
Agenda Item 2.b., regarding the re-allocation of existing authorized share capital, was not voted upon because Agenda Item 2.a. passed by the requisite majority.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the successful completion of the shareholder vote.
Investor Verification Checklist
- Confirm the effective date of the deed of amendment to the articles of association (Exhibit 99.1).
- Verify the total number of authorized shares post-amendment (220,000,000 total).
- Review the company's capitalization table to understand the current issued share count relative to the new authorized limit.